Amgen Non-Current Deferred Liabilities (Quarterly) Analysis

Amgen, Inc. (AMGN)

324.45 -1.09 (-0.33%) USD | NASDAQ | Jan 13, 16:00

323.95 -0.50 (-0.15%) After-Hours: 18:25

View Non-Current Deferred Liabilities (Quarterly) for AMGN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Liabilities (Quarterly) Benchmarks

Start Trial

Gilead Sciences, Inc.	Upgrade
Johnson & Johnson	Upgrade
Eli Lilly & Co.	--
Merck & Co., Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade